Global Morphine Market Size, Share, and COVID-19 Impact Analysis, By Type (Oral Tablets, Injection, and Capsule), By Application (Anesthesia, Cough Suppressant, Diarrhea Suppressant, and Others), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033.

Industry: Healthcare


Global Morphine Market Insights Forecasts to 2033

  • The Global Morphine Market Size was Valued at USD 22.46 Billion in 2023
  • The Market Size is Growing at a CAGR of 4.50% from 2023 to 2033
  • The Worldwide Morphine Market Size is Expected to Reach USD 34.87 Billion by 2033
  • Asia Pacific is Expected to Grow the fastest during the forecast period.


Global Morphine Market

Get more details on this report -

Request Free Sample PDF

The Global Morphine Market Size is Anticipated to Exceed USD 34.87 Billion by 2033, Growing at a CAGR of 4.50% from 2023 to 2033.


Market Overview

A strong opioid analgesic generated from the opium poppy plant is called morphine. It is a dark brown resin that has a potent opiate effect. A drug addiction and adverse effects result from consuming an excessive amount of this chemical. In the healthcare industry, morphine is working in trace amounts in a variety of pharmaceuticals. This medication is beneficial in relieving pain from the central nervous system, thus it can also be used after surgery. It is also utilized in the treatment of cancer. Medicines classified as "morphine drugs" have morphine as one of their primary active medicinal components. It is one of the best drugs for reducing pain that is currently available in the market and is frequently used to treat moderate to severe pain, especially pain brought on by trauma, surgery, and illnesses like cancer. The opium poppy plant naturally contains the narcotic painkiller morphine, which is used to alleviate moderate to severe pain. Patients with moderate to severe pain that is not sufficiently treated by alternative painkillers or other pain management techniques can find relief from their symptoms by using morphine, which operates on the central nervous system to reduce pain signals.  It relieves post-operative pain by acting on the central nervous system. Because it is euphoric and tranquil, morphine is a highly addictive substance. Because morphine is reducing pain and enhancing the quality of life for people with acute or chronic pain disorders, the market for this drug has attracted a lot of attention.


Report Coverage

This research report categorizes the market for the global morphine market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global morphine market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global morphine market.


Global Morphine Market Report Coverage

Report CoverageDetails
Base Year:2023
Market Size in 2023:USD 22.46 Billion
Forecast Period:2023-2033
Forecast Period CAGR 2023-2033 :4.50%
2033 Value Projection:USD 34.87 Billion
Historical Data for:2019-2022
No. of Pages:250
Tables, Charts & Figures:120
Segments covered:By Type, By Application, By End User and By Region
Companies covered:: Fresenius Kabi USA, Pacira BioSciences, Inc., Endo Pharmaceuticals Inc., Tris Pharma, Inc, Mundi Pharma, Purdue Pharma L.P., Taj Pharmaceuticals Limited, Mallinckrodt Pharmaceuticals, Alcaliber S.A, Johnson Matthey, Northeast Pharmaceutical Group Co., Ltd, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Bard Pharma, and other key vendors
Pitfalls & Challenges:Covid 19 Impact Challanges, Future, Growth and Analysis

Get more details on this report -

Request Free Sample PDF

Driving Factors

The increased prevalence of chronic pain illnesses such as cancer, musculoskeletal issues, and neuropathic pain has had an immense effect on the morphine industry. Over the next 20 years, the World Health Organization predicts that the number of cancer cases will rise by more than 50%.  The growing frequency of chronic pain problems is driving up demand for strong analgesics like morphine, which is driving the market's expansion. The primary purpose of this medicine is to lessen extreme discomfort. Consequently, it's also being applied to patients to help reduce their post-operative agony. It is also used in the treatment of complex diseases like cancer. Many technical advancements in the healthcare sector have increased public awareness of receiving the right care. Due to it lowering pain in the central nervous system, morphine, a narcotic analgesic, is given after surgery.


Restraining Factors

The emergence of novel generic medications that potentially displace this medication as a pain reliever is another element that could impede the market's expansion. The market dynamics may deteriorate as a result of all these issues.


Market Segmentation

The global morphine market share is classified into type, application, and end-user.


  • The oral tablets segment dominates the market with the largest market share through the forecast period.

Based on the type, the global morphine market is categorized into oral tablets, injections, and capsules. Among these, the oral tablets segment dominates the market with the largest market share through the forecast period. Oral tablets offer a practical and non-invasive approach to pain relief, enabling patients to take the drug as directed by themselves. Additionally, the controlled-release composition of oral tablets offers prolonged pain treatment over a longer period, improving patient compliance and comfort. The bulk of the morphine market is dominated by the oral tablet segment due to its widespread availability and well-established use.


  • The anesthesia segment is anticipated to grow at the fastest CAGR growth through the forecast period.

Based on the application, the global morphine market is categorized into anesthesia, cough suppressant, diarrhea suppressant, and others. Among these, the anesthesia segment is anticipated to grow at the fastest CAGR growth through the forecast period. Anesthesia plays a vital role in surgical procedures by guaranteeing patient comfort and pain control throughout the process. Because of its powerful analgesic effects, morphine is a drug of choice for anesthesiologists to reduce pain and relax patients having surgery. The need for morphine in anesthesia is predicted to rise steadily due to the rising number of surgeries conducted worldwide and improvements in surgical methods.


  • The hospitals & clinics segment accounted for the largest revenue share through the forecast period.

Based on the end-user, the global morphine market is categorized into hospitals & clinics, ambulatory surgical centers, and others. Among these, the hospitals & clinics segment accounted for the largest revenue share through the forecast period. Morphine is used extensively in hospitals and clinics, mostly to effectively manage pain in patients undergoing surgery, suffering serious injuries, or suffering from urgent medical illnesses. As a result, it is anticipated that high prescriptions are going to separate.


Regional Segment Analysis of the Global Morphine Market

  • North America (U.S., Canada, Mexico) 
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Rest of APAC)
  • South America (Brazil and the Rest of South America) 
  • The Middle East and Africa (UAE, South Africa, Rest of MEA)


North America is anticipated to hold the largest share of the global morphine market over the predicted timeframe.


Global Morphine Market

Get more details on this report -

Request Free Sample PDF

North America is projected to hold the largest share of the global morphine market over the forecast period. The region benefits from significant healthcare spending, cutting-edge medical facilities, and a well-established healthcare infrastructure. In addition, the region is highly predisposed to chronic pain diseases, such as musculoskeletal illnesses and cancer-related pain, which require the use of strong analgesics like morphine. Additionally, the existence of important market participants, favorable government policies, and rising pain management awareness all contribute to North America's leading position in the morphine market. Because of its sophisticated healthcare sector, patient population, and supportive healthcare regulations, the United States has the highest share in this region.


Asia Pacific is expected to grow at the fastest CAGR growth of the global morphine market during the forecast period. Additionally to the region's as big and expanding population, there is a greater need for pain management options among patients. The demand for morphine in the region is also fueled by growing healthcare expenditures, advancing healthcare infrastructure, and the growth of healthcare institutions in nations like China and India. Moreover, there is an important market for morphine in the Asia Pacific region due to the rising prevalence of chronic illnesses including cancer and arthritis.


Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global morphine market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.


List of Key Companies

  • Fresenius Kabi USA
  • Pacira BioSciences, Inc.
  • Endo Pharmaceuticals Inc.
  • Tris Pharma, Inc
  • Mundi Pharma
  • Purdue Pharma L.P.
  • Taj Pharmaceuticals Limited
  • Mallinckrodt Pharmaceuticals
  • Alcaliber S.A
  • Johnson Matthey
  • Northeast Pharmaceutical Group Co., Ltd
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd
  • Bard Pharma
  • Others


Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)


Recent Developments


  • In April 2023, Bard Pharma announced the launch of its new morphine sulfate oral solution in the United States. The solution is designed to be easier to swallow than tablets or capsules, and it is available in strengths of 5, 10, and 20 milligrams per milliliter.


  • In March 2023, Mundi Pharma announced the launch of its new morphine sulfate extended-release tablets in the United States. The tablets are designed to provide up to 24 hours of pain relief, and they are available in strengths of 15, 30, and 60 milligrams


Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global morphine market based on the below-mentioned segments: 


Global Morphine Market, By Type

  • Oral Tablets
  • Injection
  • Capsule


Global Morphine Market, By Application

  • Anesthesia
  • Cough Suppressant
  • Diarrhea Suppressant
  • Others


Global Morphine Market, By End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others


Global Morphine Market, By Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies